Table 2.
Group 1 > 70 years | Group 2 < 70 years | Statistical significance | |
---|---|---|---|
ECOG 0 1 |
23.9% 76.1% |
60.9% 39.1% |
p = 0.004 |
Histology squamous adenocarcinoma other |
42.8% 42.8% 14.4% |
21.7% 69.6% 8.7% |
p = 0.3 |
Stage IIIB IV |
47.6% 52.4% |
58.6% 41.4% |
p = 0.4 |
Treatment cisplatin-gemcitabine cisplatin-vinorelbine |
47.7% 52.3% |
89.2% 10.8% |
p < 0.001 |
Days of hospitalisation | 3.04 ±0.17 days | 1.2 ±0.9 days | p < 0.001 |
ECOG – Eastern Cooperative Oncology Group